Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer
(MedPage Today) -- Biomarker-directed thromboprophylaxis in the outpatient setting significantly reduced the frequency of thromboembolism in high-risk patients with gastrointestinal (GI) or lung cancers, a randomized trial showed.
Patients at...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Gastroenterology | Heart | Thrombosis